These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22045701)

  • 1. Circulating vitamin D and risk of prostate cancer--letter.
    Schwartz GG
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):246; author reply 247. PubMed ID: 22045701
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D and prostate cancer risk--a less sunny outlook?
    Mucci LA; Spiegelman D
    J Natl Cancer Inst; 2008 Jun; 100(11):759-61. PubMed ID: 18505963
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitamin D and prostate cancer survival in veterans.
    Der T; Bailey BA; Youssef D; Manning T; Grant WB; Peiris AN
    Mil Med; 2014 Jan; 179(1):81-4. PubMed ID: 24402990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
    Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
    Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the relationship between vitamin D and cancer requires dosing the bioavailable nonhydroxylated vitamin D storage in cancer tissues.
    Dreyfus M; Wion D
    Cancer; 2015 Sep; 121(18):3362-3. PubMed ID: 25990578
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.
    Miles FL; Goodman PJ; Tangen C; Torkko KC; Schenk JM; Song X; Pollak M; Thompson IM; Neuhouser ML
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28417914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and intervention trials in prostate cancer: from theory to therapy.
    Schwartz GG
    Ann Epidemiol; 2009 Feb; 19(2):96-102. PubMed ID: 18619854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
    Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
    Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and prostate cancer risk: a review of the epidemiological literature.
    Gupta D; Lammersfeld CA; Trukova K; Lis CG
    Prostate Cancer Prostatic Dis; 2009; 12(3):215-26. PubMed ID: 19350051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to investigating the relationship between vitamin d and cancer requires dosing the bioavailable nonhydroxylated vitamin d storage in cancer tissues.
    Shui IM; Giovannucci E
    Cancer; 2015 Sep; 121(18):3363-4. PubMed ID: 25990463
    [No Abstract]   [Full Text] [Related]  

  • 12. The comparison between vitamin d concentration in upper silesia patients with prostate cancer and with benign prostatic hyperplasia.
    Wieczorek K; Braczkowski RS; Skrzypek M; Stryjewski PJ; Kuczaj A; Al-Srory G
    J Biol Regul Homeost Agents; 2015; 29(1):207-11. PubMed ID: 25864760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.
    Faupel-Badger JM; Diaw L; Albanes D; Virtamo J; Woodson K; Tangrea JA
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2784-6. PubMed ID: 18086789
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin D and cancer: an overview on epidemiological studies.
    Ordóñez Mena JM; Brenner H
    Adv Exp Med Biol; 2014; 810():17-32. PubMed ID: 25207358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
    Schwartz GG
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1447-9. PubMed ID: 25085835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.
    Sawada N; Inoue M; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Tsugane S
    Eur J Clin Nutr; 2017 Jan; 71(1):132-136. PubMed ID: 27759068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium, dairy, and prostate cancer.
    Heaney RP
    Br J Cancer; 2007 Mar; 96(6):1008; author reply 1009. PubMed ID: 17342083
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of vitamin D in prostatic carcinoma].
    Wilczek H; Vachalovský
    Cas Lek Cesk; 1996 Nov; 135(22):716-8. PubMed ID: 8998822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer.
    Choo CS; Mamedov A; Chung M; Choo R; Kiss A; Danjoux C
    Nutr Res; 2011 Jan; 31(1):21-6. PubMed ID: 21310302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between pre-treatment serum 25-hydroxyvitamin D and survival in newly diagnosed stage IV prostate cancer.
    Gupta D; Trukova K; Popiel B; Lammersfeld C; Vashi PG
    PLoS One; 2015; 10(3):e0119690. PubMed ID: 25774530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.